Expanding Product Portfolio Creso Pharma's recent launch of Green Goo products in Canada and its focus on cannabis and hemp derived products highlight an opportunity to explore partnerships for distribution and retail channels in North America and other regions seeking innovative natural health solutions.

Strategic Acquisitions The company's acquisitions of Health House At Home and Health House International demonstrate a growth strategy through diversification into medicinal cannabis and health services, suggesting potential collaborative opportunities to expand product offerings and market reach.

Regulatory & Distribution Partnerships Creso's partnership with Swiss-based pharmacy Apotheke Dr. Hysek for importing MDMA and psilocybin products indicates an openness to regulatory collaborations, opening avenues for sales roles focused on entering emerging psychedelics markets and navigating complex legal environments.

Funding & Market Growth Securing A$2.5 million through convertible notes and revenue up to $10 million reflect a company in growth mode, signaling opportunities for sales efforts around expanding existing product lines, entering new markets, or developing new formulations within the biotechnology sector.

Technology & Innovation Utilization of cutting-edge research and science in product development positions Creso Pharma as a forward-looking organization. This creates sales potential by offering innovative, scientifically-backed health and wellness products to health-conscious consumers and institutional buyers.